ETA antagonist delays disease progression, improves quality of life in late-stage prostate cancer May 22, 2001
Abarelix as a new hormonal therapy for safely inducing medical castration in prostate cancer May 21, 2001
ASCO presentation documents safety of TLK-286 over wide dose range, efficacy in advanced cancer May 21, 2001
RSS